NOTICE OF PUBLICATION OF THE 10 MAY 2022

SHAREHOLDERS' MEETING MINUTES

Verdellino (BG), 31 May 2022

The Company states that a copy of the minutes of the 10 May 2022 Ordinary Shareholders' Meeting, which approved, among the others, 31 December 2021 financial statements, the dividend distribution and the renewal of the authorization to buyback and dispose of treasury shares, is publicly available on its website www.finefoods.it, in the Governance / Shareholders' Meetings section, at the storage system 1INFO www.1info.itand its registered office in Zingonia-Verdellino, via Berlino, 39.

***

This press release is available on the Fine Foods website www.finefoods.it,in the Investor Relations/Press Releases section.

***

Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Euronext STAR Milan, is an Italian independent Contract Development & Manufacturing Organisation (CDMO). It develops and manufactures contract products for the pharmaceutical and nutraceutical industries. Fine Foods is also active in the cosmetics, biocides and medical devices industries with its acquisition of Pharmatek-PMC and the most recent Euro Cosmetic acquisition.

Founded in 1984, from a pharmaceutical and nutraceutical synergy, its main objective is to research and develop quality and innovation on behalf of its customers. With € 193 million revenue in 2021 and an 11 per cent CAGR over the last decade, it is a growing and future-oriented company.

The sustainability of the business model and the holistic approach to ESG, together with product innovation, are drivers that will allow the company to fully develop its intrinsic potential.

***

For information:

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Investor Relations

tel. +39 035 4821382 ir@finefoods.it

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia

CF / P.IVA IT 09320600969

T. +39 035 4821382 info@finefoods.it

CAP. SOC. € 22.770.445,02

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Fine Foods & Pharmaceuticals NTM S.p.A. published this content on 31 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 May 2022 09:49:01 UTC.